A tandem series of adenine/thymine (A/T) repeats with a single guanine:cytosine (G:C) base pair were introduced to an Igk (immunoglobulin kappa; Vk167) transgene. The cytosine (C) residue marks a site at which deamination to uracil (U) can occur, initiating somatic hypermutations of upstream and downstrean A/T residues. This "TgG" line, in which the cytosine was on the 3'->5' strand of the gene, showed very few mutations in the activated B cell A/T repeat region of 4-12 month old mice. This strain may be useful in studying somatic hypermutations associated with the rapid diversification of antibodies during immune responses to antigen.
Dr. David Schatz, Yale University School of Medicine, HHMI
Genetic Background | Generation |
---|---|
|
Allele Type |
---|
Transgenic (Inserted expressed sequence) |
Alternating EcoRV and PvuII sites and a tandem series of adenine/thymine (A/T) repeats with a single guanine:cytosine (G:C) base pair were introduced to an Igk (immunoglobulin kappa; VΚ167) transgene. The cytosine (C) residue marks a site at which deamination to uracil (U) can occur, initiating somatic hypermutations of upstream and downstrean A/T residues. This "TgG" line, in which the cytosine was on the 3'->5' strand of the gene, showed very few mutations in the activated B cell A/T repeat region of 4-12 month old mice. This strain may be useful in studying somatic hypermutations associated with the rapid diversification of antibodies during immune responses to antigen. Hemizygotes are viable, fertile, normal in size and do not display any gross physical or behavioral abnormalities.
VΚ167/PEPS, indirectly derived from BALB/c myeloma protein MPOC 167, was designed to carry alternating EcoRV and PvuII sites (EPS) in a transgene with a truncated region upstream of the promoter.
The Igk (immunoglobulin kappa) sequence was further modified in the current strain through the insertion of 5 tandem repeats of a 20-bp adenine/thymine (A/T) fragment including a single guanine:cytosine (G:C) base pair in the central repeat. In this "TgG" line, the cytosine was placed on the 3'->5' strand of the DNA.
The transgene was initially introduced to a C57BL/6-SJL background, and subsequently crossed to BALB/cByJ or C57BL/6 inbred mice for a total of 8 generations by the donating investigators.
Expressed Gene | Igk, immunoglobulin kappa chain complex, mouse, laboratory |
---|---|
Site of Expression |
Allele Name | transgene insertion G07, David Schatz |
---|---|
Allele Type | Transgenic (Inserted expressed sequence) |
Allele Synonym(s) | TgG |
Gene Symbol and Name | Tg(Igk*G)G07Dgs, transgene insertion G07, David Schatz |
Gene Synonym(s) | |
Promoter | Igk, immunoglobulin kappa chain complex, mouse, laboratory |
Expressed Gene | Igk, immunoglobulin kappa chain complex, mouse, laboratory |
Strain of Origin | C57BL/6 and SJL |
Chromosome | UN |
Molecular Note | Vk167/PEPS is an Igk transgene with a truncated region upstream of the promoter. The Igk (immunoglobulin kappa) sequence was further modified through the insertion, near the 3' end of the variable region of Igk, of 5 tandem repeats of a 20-bp adenine/thymine (A/T) fragment in the same orientation as the insert in the TgA line but includes a single guanine:cytosine (G:C) base pair in the central repeat. In this "TgG" line, the cytosine was placed on the 3'->5' strand of the DNA. |
Mutations Made By | Dr. David Schatz, Yale University School of Medicine, HHMI |
When maintained as a live colony, hemizygotes may be bred with wildtype mice.
When using the STOCK Tg(Igk*G)G07Dgs/J mouse strain in a publication, please cite the originating article(s) and include JAX stock #008719 in your Materials and Methods section.
Facility Barrier Level Descriptions
Service/Product | Description | Price |
---|---|---|
Hemizygous or Non carrier for Tg(Igk*G)G07Dgs |
Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.
The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.
What information were you hoping to find through your search?
How easy was it to find what you were looking for?
We may wish to follow up with you. Enter your email if you are happy for us to connect and reachout to you with more questions.
Please Enter a Valid Email Address
Thank you for sharing your feedback! We are working on improving the JAX Mice search. Come back soon for exciting changes.